share_log

中关村(000931.SZ):下属公司多多药业盐酸氨溴索注射液收到国家药监局《受理通知书》

Zhongguancun (000931.SZ): Subsidiary company Duoduo Pharmaceutical Ambroxol Hydrochloride Injection received the “Notice of Acceptance” from the State Drug Administration

Gelonghui Finance ·  Apr 29 03:53

Gelonghui, April 29丨Zhongguancun (000931.SZ) announced that Duoduo Pharmaceutical Co., Ltd. (hereinafter: Duoduo Pharmaceutical), a subsidiary of the company, recently received the “Notice of Acceptance” of the registration application for the chemical generic drug ambroxol hydrochloride injection issued by the China Drug Administration (hereinafter referred to as the State Drug Administration).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment